Neuropace Inc
NASDAQ:NPCE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
Paladin Energy Ltd
ASX:PDN
|
AU |
|
Yamaichi Electronics Co Ltd
TSE:6941
|
JP |
|
Gke Corporation Ltd
SGX:595
|
SG |
|
Indocement Tunggal Prakarsa Tbk PT
IDX:INTP
|
ID |
|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
US |
|
ABC Arbitrage SA
OTC:ABCCF
|
FR |
|
Ampco-Pittsburgh Corp
NYSE:AP
|
US |
|
M
|
Mars Acquisition Corp
NASDAQ:MARX
|
US |
|
Beauty Health Co
NASDAQ:SKIN
|
US |
|
E
|
Everest Securities JSC
VN:EVS
|
VN |
|
Dollar Industries Ltd
NSE:DOLLAR
|
IN |
|
A
|
Anthem Biosciences Ltd
NSE:ANTHEM
|
IN |
|
Kintara Therapeutics Inc
NASDAQ:KTRA
|
US |
|
S
|
Sibanye Stillwater Ltd
JSE:SSW
|
ZA |
|
Future Battery Minerals Ltd
ASX:FBM
|
AU |
|
Computime Group Ltd
HKEX:320
|
HK |
|
A
|
Abak SA
WSE:ABK
|
PL |
|
M
|
Metsera Inc
NASDAQ:MTSR
|
US |
|
Nissan Motor Co Ltd
TSE:7201
|
JP |
|
A
|
Aim Commercial Growth Freehold and Leasehold Real Estate Investment Trust
SET:AIMCG
|
TH |
Bankruptcy Probability
Neuropace Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Neuropace Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Neuropace Inc
NASDAQ:NPCE
|
496.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
179.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
164.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
130.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
33.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Neuropace Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Neuropace Inc has total debt of 58.9m USD. This includes both short-term (0 USD) and long-term (58.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
